Key facts
- This page summarizes Joseph Michael Harris's Form 4 filing for NEPHROS INC (NEPH).
- 1 reported transaction and 4 derivative rows are listed below.
- Accepted by SEC: 03 Jan 2025, 17:07.
Joseph Michael Harris - 01 Jan 2025 Form 4 Insider Report for NEPHROS INC (NEPH)
- Reporting relationship
- Director
- Issuer ticker
- NEPH
- Reported as of
- 01 Jan 2025
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 03 Jan 2025, 17:07:23 UTC
- Prior SEC filing
- 16 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christopher Melsha as attorney-in-fact for Joseph M. Harris pursuant to power of attorney previously filed.
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Joseph Michael Harris filed Form 4 for NEPHROS INC (NEPH) on 03 Jan 2025.
Change
- Previous filing in this sequence was filed on 16 May 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NEPH
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 17,693
- Date
- 01 Jan 2025
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NEPH
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +7,050
- Change %
- Price
- $0.000000
- Shares after
- 7,050
- Date
- 01 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,050
- Exercise price
- $1.47
- Footnotes
- F4
NEPH
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,115
- Date
- 01 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 13,115
- Exercise price
- $1.25
- Footnotes
- F1
NEPH
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,080
- Date
- 01 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,080
- Exercise price
- $1.07
- Footnotes
- F2
NEPH
holding
Derivative
Stock Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,323
- Date
- 01 Jan 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 7,323
- Exercise price
- $2.14
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Fully exercisable.
Footnote F2
This option vests as to 2,360 shares on each of 1/5/23, 1/5/24 and 1/5/25.
Footnote F3
This option vests as to 2,441 shares on each of 5/14/24, 5/14/25 and 5/14/26.
Footnote F4
Represents options granted to the reporting person for his service on the Company's Board of Directors for 2024. This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.